查詢結果分析
相關文獻
- High-Frequency Oscillatory Ventilation in Premature Infants
- Experiences with High-Frequency Oscillatory Ventilation in Premature Infants with Respiratory Distress Syndrome
- Home Oxygen Therapy for Chronic Lung Disease in Very Low-Birth-Weight Infants
- 早產兒容易肺部不成熟
- 早產兒呼吸窘迫症候群之預防及治療
- 以表面張力素治療早產兒呼吸窘迫症候群的概況
- 慢性肺部疾病
- 早產兒呼吸窘迫症候群之預防與治療
- Persistent Pulmonary Hypertension in Preterm Infants with RDS
- 擺位姿勢對嬰幼兒肺功能的影響
頁籤選單縮合
題 名 | High-Frequency Oscillatory Ventilation in Premature Infants=早產兒使用高頻振盪式呼吸器 |
---|---|
作 者 | 賴縵光; 鄭玫枝; 宋文舉; 劉靜雯; 陳淑貞; 黃碧桃; | 書刊名 | 中華醫學雜誌 |
卷 期 | 62:12 1999.12[民88.12] |
頁 次 | 頁879-885 |
分類號 | 417.5171 |
關鍵詞 | 慢性肺病; 傳統式呼吸器; 高頻振盪式呼吸器; 早產兒; 呼吸窘迫症; Chronic lung disease; Conventional ventilation; High frequency oscillatory ventilation; Premature infants; Respiratory distress syndrome; |
語 文 | 英文(English) |
中文摘要 | 背景:儘管有傳統式呼吸器之輔助,但是肺部疾病仍是早產兒死亡之主要原因。本文比較早產兒早期使用高頻振盪式與傳統式呼吸器之結果,評估高頻振盪式呼吸器在早產兒中使用之有效性及安全性。 方法:研究對象為1997年1月至1998年6月在新生兒加護病房使用呼吸器之35位早產兒(18位用高頻振盪式呼吸器,17位用傳統式呼吸器)。他們的選取標準為:懷孕遇數<35遇或出生體重<1,751 g,且無致死性先天畸型、菌血症、胎兒水腫、先天性橫膈膜缺損或僅因呼吸暫停而須插管者。他們之基本資料、氣體交換、呼吸器使用情況、慢性肺病發生率、存活率及各種早產兒常見之併發症均有詳鈿記錄以作分析。 結果:胸部X光顯示,所有早產兒都有不等程度之呼吸窘迫症。高頻振盪式呼吸器所需之氣管插管時間比傳統式呼吸器顯著較短(p<0.05),其慢性肺病發生率亦較低。至於其它早產兒之併發症(如顱內出血、開放性動脈導管、壞死性腸炎、氣體洩漏症候群及早產兒視網膜病變等),在兩組間皆無統計學差異。 結論:高頻振盪式呼吸器用於呼吸窘迫症併呼吸衰竭之早產兒,可有效地縮短氣管插管時間,且不增加其併發症之發生率,是一種既有效且安全的早產兒呼吸治療方式。 |
英文摘要 | Background: Although assisted ventilation has reduced the mortality rate of premature infants, pulmonary disease is still the major cause of morbidity and mortality in very low birth weight infants. We designed this study to evaluate the efficacy and safety of high-frequency oscillatory ventilation (HFOV) in premature infants and to compare the outcome for early intervention with HFOV versus conventional ventilation (CV). Methods: From January, 1997, to June, 1998, we analyzed premature infants with respiratory failure who required mechanical ventilation and supplemental oxygen to support adequate gas exchange in our neonatal intensive care unit. Patients were eligible if their gestational age was less than 35 weeks or their birth weight was less than 1,751 g. A total of 35 neonates were enrolled in the study. Eighteen infants were treated with HFOV, and 17 infants were treated with CV. They were treated with early intervention of HFOV or CV, within 24 hours-of-age. Patients were excluded if a lethal congenital anomaly, bacteremia, hydrops fetalis, congenital diaphragmatic hernia or intubation only for apnea were noted. Data on demographics, gas exchange and outcome parameters were collected for. each patient enrolled in the study. Results: No differences were noted in the demographic features between the study groups. All of the enrolled patients suffered from variable grades of respiratory distress syndrome. A significantly shorter intubation period was found in the HFOV group compared with the CV group (2.8 ± 1.5 days vs 8.8 ± 9.4 days; p = 0.013 ). Conclusions: HFOV is a safe and effective therapy for premature infants with respiratory failure due to respiratory distress syndrome. |
本系統中英文摘要資訊取自各篇刊載內容。